Letter: Debrisoquine, guanethidine, and bethanidine in hypertension.

Letter: Debrisoquine, guanethidine, and bethanidine in hypertension. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Letter: Debrisoquine, guanethidine, and bethanidine in hypertension. Abstract Text:

Letter: Debrisoquine, guanethidine, and bethanidine in hypertension. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Letter: Debrisoquine, guanethidine, and bethanidine in hypertension. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: British medical journal

VOLUME: 2

Page Numbers: 278

Journal Abbreviation: Br Med J

ISSN: 0007-1447

DAY: 3

MONTH: May

YEAR: 1975

Letter: Debrisoquine, guanethidine, and bethanidine in hypertension. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 372673

Letter: Debrisoquine, guanethidine, and bethanidine in hypertension. Keywords Mesh Terms:

KEYWORDS: Isoquinolines

MESH TERMS: therapeutic use

Chemical & Substance for Abstract: Letter: Debrisoquine, guanethidine, and bethanidine in hypertension. Information

Substance Name: Bethanidine

Registry Number: 55-73-2

Grant and Affiliation Information for Letter: Debrisoquine, guanethidine, and bethanidine in hypertension.

AFFILIATION:

Country: ENGLAND

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Br Med J

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Letter: Debrisoquine, guanethidine, and bethanidine in hypertension Related Publications

• A device for continuous recording of concentration of Evans blue dye in whole blood and its application to determination of cardiac output.
• Beta-1-adrenoceptor agonists with low adenylate cyclase activation--theoretical and clinical implications.
• Cardiac metabolism in myocardial failure.
• Chemicals Introduced in Foods. Food and Nutrition Section. Report of the Chairman of the Committee on Chemicals Introduced in Foods.
• Complete transposition of the aorta and a levoposition of the pulmonary artery; clinical, physiological, and pathological findings.
• HIV Stigma and Social Support among African Americans.
• Improving public access to environmental information in China.
• Increasing HIV testing among latinos by bundling HIV testing with other tests.
• Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system.
• Internal carotid false aneurysm after thermocoagulation of the gasserian ganglion.
• Letter: Debrisoquine, guanethidine, and bethanidine in hypertension.
• Microsomal epoxide hydrolase deletion enhances tyrosine hydroxylase phosphorylation in mice after MPTP treatment.
• Neuroprotection with pioglitazone against LPS insult on dopaminergic neurons may be associated with its inhibition of NF-kappaB and JNK activation and suppression of COX-2 activity.
• Not Available
• Physiologic methods in the diagnosis of congenital heart disease.
• Physiological studies in congenital heart disease; the circulation in patients with isolated septal defects.
• Physiological studies in congenital heart disease; the physiological findings in two patients with complete transposition of the great vessels.
• Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt.
• Protective properties afforded by pioglitazone against intrastriatal LPS in Sprague-Dawley rats.
• Pulmonary arterial hypertension in congenital heart disease.
• Rapid marked increase in plasma renin in rats treated with inhibitors of the renin system. Effects of 1-sar-8-ala-angiotensin II and of a synthetic converting enzyme inhibitor (nonapeptide, SQ 20.881) on normal and adrenalectomized rats.
• Recent studies of cardiac failure with relation to the action of digitalis.
• Relation between renin substrate and acute phase proteins. Studies of normal and adrenalectomized rats.
• Renal hyperemia after the intravenous infusion of adenylic acid adenosine, or adenosine-triphosphate in the dog.
• Species specific differences in converting enzyme and in angiotensin I.
• Structural changes and ability to release renin in auto- and allo-transplants of mouse submaxillary glands.
• The metabolism of the heart.
• The surgical treatment of mitral stenosis and its physiological consequences.
• The tissue reaction to implanted plastics.
• The value of catheterization of the heart and other physiologic procedures in the diagnosis of congenital heart disease.